WhiteOak Capital Pharma and Healthcare Fund
Sectoral-PharmaVery HighOPEN-ENDED
- NAV as on 9 Nov 2026
- ₹17.53+2.57%1 day
- Return since launch
- 21.2%
- 52-week range
- ₹12.93 — ₹17.17
- AUM
- ₹1,003 Cr
WhiteOak Capital Pharma and Healthcare Fund is a Sectoral-Pharma equity fund from WhiteOak Capital Mutual Fund with ₹1,003 Cr under management, launched in 2024. The expense ratio is 2.72% and the SEBI riskometer reading is Very High.
Performance
WhiteOak Capital Pharma and Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +24.3% against +19.9% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 35.4% | +14.6 pts | 20.8% | 29.1% |
| 2Y | 23.7% | +4.6 pts | 19.1% | 17.6% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 8.2% | −0.2 pts | 8.4% | 8.5% |
| 3M | 4.2% | +0.5 pts | 3.7% | 3.7% |
| 6M | 16.4% | +2.4 pts | 14.0% | 13.6% |
| 1Y | 23.6% | +2.9 pts | 20.8% | 19.4% |
| 2Y | 16.3% | +5.4 pts | 10.8% | 9.5% |
Since launch (16 Jan 2024): 21.2%
Calendar-year returns
Category average0.1%
Show as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | 0.1% | +2.1 pts | -2.0% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.71%
Expense ratio as on 6 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.93%
- Brokerage
- 0.12%
- Transaction charges
- 0.01%
- Statutory levies
- 0.65%
- Exit load
- Exit load of 1%, if redeemed within 1 months.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Very High
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
Portfolio
WhiteOak Capital Pharma and Healthcare Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity91.4%
- Debt8.0%
- Other0.5%
Market cap split
- Large32.1%
- Mid24.5%
- Small43.3%
- P/E
- 51.00
- P/B
- 7.34
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Divi's Laboratories Ltd. | Healthcare | 7.73% | ₹77.50 Cr | +1.57% | +0.78% | +0.49% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 6.57% | ₹65.86 Cr | +0.07% | +0.10% | +3.15% |
| Torrent Pharmaceuticals Ltd. | Healthcare | 5.78% | ₹58.00 Cr | — | — | — |
| Others | Others | 5.66% | ₹56.73 Cr | +8.57% | +1.85% | +14.25% |
| Cipla Ltd. | Healthcare | 5.11% | ₹51.25 Cr | +4.72% | — | +9.11% |
| Laurus Labs Ltd. | Healthcare | 4.91% | ₹49.28 Cr | +8.62% | +7.86% | +8.57% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 3.66% | ₹36.71 Cr | +0.52% | +0.64% | +0.80% |
| Aurobindo Pharma Ltd. | Healthcare | 3.38% | ₹33.87 Cr | +3.47% | +4.05% | — |
| Sai Life Sciences Ltd. | Healthcare | 3.03% | ₹30.37 Cr | +3.01% | +2.77% | +2.89% |
| Ipca Laboratories Ltd. | Healthcare | 2.66% | ₹26.65 Cr | +0.86% | +2.17% | — |
| Zydus Lifesciences Ltd. | Healthcare | 2.60% | ₹26.07 Cr | +2.07% | +0.83% | — |
| Neuland Laboratories Ltd. | Healthcare | 2.40% | ₹24.08 Cr | +2.31% | +1.42% | +3.20% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 2.17% | ₹21.76 Cr | +1.81% | +1.34% | — |
| CORONA Remedies Ltd. | Healthcare | 2.16% | ₹21.64 Cr | +2.38% | +2.27% | — |
| Mankind Pharma Ltd. | Healthcare | 2.14% | ₹21.51 Cr | +1.77% | — | +2.49% |
| Thyrocare Technologies Ltd. | Healthcare | 2.10% | ₹21.07 Cr | +1.96% | +1.56% | +1.19% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 1.91% | ₹19.18 Cr | +0.67% | +0.89% | +1.63% |
| Ajanta Pharma Ltd. | Healthcare | 1.86% | ₹18.63 Cr | +1.54% | +2.11% | +1.75% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 1.71% | ₹17.11 Cr | +3.09% | +3.16% | +4.09% |
| Max Healthcare Institute Ltd. | Healthcare | 1.70% | ₹17.09 Cr | +0.51% | +0.39% | +3.19% |
| Shaily Engineering Plastics Ltd. | Materials | 1.70% | ₹17.01 Cr | +1.26% | +1.58% | +1.91% |
| Global Health Ltd. | Healthcare | 1.68% | ₹16.85 Cr | — | — | — |
| Narayana Hrudayalaya Ltd. | Healthcare | 1.49% | ₹14.94 Cr | +1.64% | +1.72% | — |
| Anthem Biosciences Ltd. | Healthcare | 1.45% | ₹14.56 Cr | +1.06% | — | +1.51% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 1.44% | ₹14.42 Cr | +1.41% | +0.94% | +2.48% |
| Onesource Specialty Pharma Ltd. | Healthcare | 1.43% | ₹14.36 Cr | +1.15% | — | +0.42% |
| Acutaas Chemicals Ltd. | Healthcare | 1.34% | ₹13.47 Cr | +2.22% | +2.61% | +0.94% |
| Navin Fluorine International Ltd. | Chemicals | 1.31% | ₹13.09 Cr | +1.15% | +1.41% | +0.75% |
| Fortis Healthcare Ltd. | Healthcare | 1.26% | ₹12.62 Cr | +3.39% | +0.07% | +6.69% |
| Aarti Pharmalabs Ltd. | Services | 1.11% | ₹11.16 Cr | +0.80% | +0.48% | — |
| Procter & Gamble Health Ltd. | Healthcare | 1.09% | ₹10.89 Cr | +1.23% | — | — |
| Molbio Diagnostics Ltd. | Healthcare | 1.06% | ₹10.67 Cr | — | — | — |
| Rainbow Children's Medicare Ltd. | Healthcare | 1.06% | ₹10.63 Cr | +1.36% | +0.80% | — |
| Piramal Pharma Ltd. | Healthcare | 0.98% | ₹9.82 Cr | — | — | +1.47% |
| Aether Industries Ltd. | Chemicals | 0.97% | ₹9.72 Cr | +1.26% | +1.38% | — |
| Kovai Medical Center & Hospital Ltd. | Healthcare | 0.88% | ₹8.83 Cr | +1.01% | +1.20% | +1.65% |
| Gland Pharma Ltd. | Healthcare | 0.86% | ₹8.62 Cr | +1.85% | — | +1.94% |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.74% | ₹7.44 Cr | +0.71% | — | — |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.67% | ₹6.76 Cr | +0.68% | — | +1.66% |
| Supriya Lifescience Ltd. | Healthcare | 0.64% | ₹6.43 Cr | +0.73% | +0.64% | +0.79% |
| Vimta Labs Ltd. | Healthcare | 0.62% | ₹6.17 Cr | +0.66% | — | — |
| Innova Captab Ltd. | Healthcare | 0.59% | ₹5.88 Cr | +1.05% | — | — |
| Nephrocare Health Services Ltd. | Healthcare | 0.53% | ₹5.31 Cr | +0.49% | — | — |
| Manipal Health Enterprises Ltd. | Healthcare | 0.48% | ₹4.80 Cr | — | — | — |
| Sudeep Pharma Ltd. | Healthcare | 0.42% | ₹4.23 Cr | +0.48% | +0.67% | — |
| Biocon Ltd. | Healthcare | 0.39% | ₹3.90 Cr | — | — | — |
| Tatva Chintan Pharma Chem Ltd. | Chemicals | 0.38% | ₹3.85 Cr | +0.17% | +0.21% | — |
| Orchid Pharma Ltd. | Healthcare | 0.38% | ₹3.76 Cr | +0.27% | +0.19% | +0.45% |
| Zota Health Care Ltd. | Healthcare | 0.37% | ₹3.73 Cr | +0.52% | +0.55% | +0.56% |
| Reserve Bank of India | Financial | 0.34% | ₹3.39 Cr | +0.50% | +0.89% | +0.27% |
| Novartis India Ltd. | Healthcare | 0.22% | ₹2.25 Cr | — | — | — |
| Laxmi Dental Ltd. | Healthcare | 0.21% | ₹2.12 Cr | +0.20% | — | +0.22% |
| Bharat Parenterals Ltd. | Healthcare | 0.09% | ₹0.90 Cr | — | — | — |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 0.07% | 6.57% | +6.50% |
| Others | 2.58% | 5.13% | +2.55% |
| Dr. Reddy's Laboratories Ltd. | 0.00% | 1.91% | +1.91% |
| Max Healthcare Institute Ltd. | 0.40% | 1.70% | +1.30% |
| Pfizer Ltd. | 1.14% | 0.00% | -1.14% |
| Mankind Pharma Ltd. | 0.00% | 1.04% | +1.04% |
| Torrent Pharmaceuticals Ltd. | 6.78% | 5.78% | -1.00% |
| Piramal Pharma Ltd. | 0.00% | 0.98% | +0.98% |
| Poly Medicure Ltd. | 0.76% | 0.00% | -0.76% |
| Divi's Laboratories Ltd. | 8.45% | 7.73% | -0.72% |
| Manipal Health Enterprises Ltd. | 1.15% | 0.48% | -0.67% |
| Neuland Laboratories Ltd. | 2.88% | 2.40% | -0.48% |
| Onesource Specialty Pharma Ltd. | 1.01% | 1.43% | +0.42% |
| Fortis Healthcare Ltd. | 1.65% | 1.26% | -0.39% |
| Shaily Engineering Plastics Ltd. | 2.01% | 1.70% | -0.32% |
| Sai Life Sciences Ltd. | 3.32% | 3.03% | -0.29% |
| Cipla Ltd. | 2.00% | 1.71% | -0.29% |
| Narayana Hrudayalaya Ltd. | 1.76% | 1.49% | -0.27% |
| Global Health Ltd. | 1.92% | 1.68% | -0.24% |
| Anthem Biosciences Ltd. | 1.68% | 1.45% | -0.23% |
| Novartis India Ltd. | 0.00% | 0.22% | +0.22% |
| Navin Fluorine International Ltd. | 1.53% | 1.31% | -0.22% |
| Krishna Institute of Medical Sciences Ltd | 1.92% | 1.71% | -0.21% |
| Cohance Lifesciences Ltd. | 0.21% | 0.00% | -0.21% |
| Rainbow Children's Medicare Ltd. | 1.27% | 1.06% | -0.21% |
| Thyrocare Technologies Ltd. | 2.31% | 2.10% | -0.21% |
| Jupiter Life Line Hospitals Ltd. | 0.87% | 0.67% | -0.20% |
| CORONA Remedies Ltd. | 2.35% | 2.16% | -0.19% |
| Dr. Lal Pathlabs Ltd. | 2.35% | 2.17% | -0.18% |
| Aurobindo Pharma Ltd. | 1.62% | 1.44% | -0.18% |
| Procter & Gamble Health Ltd. | 1.25% | 1.09% | -0.17% |
| Vijaya Diagnostic Centre Ltd. | 1.59% | 1.44% | -0.15% |
| Ajanta Pharma Ltd. | 1.72% | 1.86% | +0.14% |
| Vimta Labs Ltd. | 0.73% | 0.62% | -0.12% |
| Senores Pharmaceuticals Ltd. | 0.85% | 0.74% | -0.11% |
| Kovai Medical Center & Hospital Ltd. | 0.99% | 0.88% | -0.11% |
| Acutaas Chemicals Ltd. | 1.44% | 1.34% | -0.10% |
| Biocon Ltd. | 0.48% | 0.39% | -0.09% |
| Molbio Diagnostics Ltd. | 0.98% | 1.06% | +0.08% |
| Nephrocare Health Services Ltd. | 0.61% | 0.53% | -0.08% |
| Laurus Labs Ltd. | 1.36% | 1.30% | -0.06% |
| Sudeep Pharma Ltd. | 0.47% | 0.42% | -0.05% |
| Bharat Parenterals Ltd. | 0.04% | 0.09% | +0.05% |
| Supriya Lifescience Ltd. | 0.60% | 0.64% | +0.04% |
| Apollo Hospitals Enterprise Ltd. | 0.23% | 0.19% | -0.04% |
| Reserve Bank of India | 0.37% | 0.34% | -0.04% |
| Zota Health Care Ltd. | 0.34% | 0.37% | +0.04% |
| Orchid Pharma Ltd. | 0.41% | 0.38% | -0.03% |
| Laxmi Dental Ltd. | 0.24% | 0.21% | -0.03% |
| Zydus Lifesciences Ltd. | 2.58% | 2.60% | +0.02% |
| Innova Captab Ltd. | 0.61% | 0.59% | -0.02% |
| Aarti Pharmalabs Ltd. | 1.10% | 1.11% | +0.02% |
| Gland Pharma Ltd. | 0.85% | 0.86% | +0.01% |
| Tatva Chintan Pharma Chem Ltd. | 0.39% | 0.38% | -0.01% |
| Aether Industries Ltd. | 0.97% | 0.97% | 0.00% |
| Ipca Laboratories Ltd. | 2.66% | 2.66% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,934 Cr | 1.89% | 36.5% | 20.8% | 21.6% |
 SBI Healthcare Opportunities Fund | ₹6,067 Cr | 1.98% | 35.0% | 19.9% | 22.6% |
 HDFC Pharma And Healthcare Fund | ₹3,501 Cr | 2.11% | 39.6% | 25.8% | — |
 Mirae Asset Healthcare Fund | ₹3,494 Cr | 2.01% | 37.3% | 20.2% | 21.1% |
 UTI Healthcare Fund | ₹1,430 Cr | 2.21% | 30.6% | 18.4% | 21.1% |
 ICICI Prudential Nifty Pharma Index Fund | ₹177 Cr | 1.13% | 39.9% | 19.9% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund managers
- Ashish AgrawalPGDBM in Finance from Institute of Management Technology, Ghaziabad and Bachelor of Commerce from University of LucknowPrior to joining Whiteoak Capital AMC, he was working with Motilal Owal Asset Management Co. Ltd from 2016 till date. Citigroup Global Markets Ltd from 2010 to 2016
- Dheeresh PathakMr. Pathak has done B.E in Electronics Engineering and a PGDBM from MDI GurgaonPrior to joining WhiteOak Capital Mutual Fund, he has worked with Goldman Sachs
- Piyush BaranwalMr.Piyush Baranwal is a B. Tech. in Electronics and communication from Manipal Institute of Technology,Manipal.He completed PGDBM in Finance from S.P.Jain Institute of Management and Reserch and CFA.Prior to joining WhiteOak Capital Mutual Fund he has worked with BOI AXA, Morgan Stanley Investment Management (Jan, 2011-June, 2014) and Principal Pnb AMC as a Dealer- Fixed Income (May, 2008-Jan, 2011).
- Ramesh MantriMr. Mantri is an MBA, CFA and CAPrior to joining WhiteOak Capital Mutual Fund, he has worked with WhiteOak Capital Management, Ashoka Capital Advisers, Smith Management, and CRISIL.
- Trupti AgrawalMs. Agrawal has done B.Com and CA.Prior to joining WhiteOak Capital Mutual Fund, she has worked with L&T Infrastructure Finance Co. Ltd. and Ernst & Young.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
₹
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months16.38% absolute | ₹60,000 | ₹69,828 | 16.38% | |
| 1 year23.64% annualised | ₹1,20,000 | ₹1,36,533 | 13.78% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.
What is the NAV of WhiteOak Capital Pharma and Healthcare Fund?
The NAV of WhiteOak Capital Pharma and Healthcare Fund is ₹17.53 as on 9 Nov 2026.
What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund?
The expense ratio of WhiteOak Capital Pharma and Healthcare Fund is 2.72% per year.
What is the minimum SIP amount for WhiteOak Capital Pharma and Healthcare Fund?
You can start a SIP in WhiteOak Capital Pharma and Healthcare Fund with ₹3,000 a month.
Is there a lock-in or exit load on WhiteOak Capital Pharma and Healthcare Fund?
Lock-in: None. Exit load: Exit load of 1%, if redeemed within 1 months..
How risky is WhiteOak Capital Pharma and Healthcare Fund?
WhiteOak Capital Pharma and Healthcare Fund is rated Very High on the SEBI riskometer and belongs to the Sectoral-Pharma category.
Which fund house manages WhiteOak Capital Pharma and Healthcare Fund?
WhiteOak Capital Pharma and Healthcare Fund is managed by WhiteOak Capital Mutual Fund, which runs 23 schemes with ₹44,845 Cr under management.